project id: TCGA-STAD; case submitter id: TCGA-VQ-A8PM; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.61; rna integrity number: 7.0; age at index: 56; days to birth: -20665; days to death: 57; ethnicity: not reported; gender: male; race: white; vital status: Dead; year of birth: 1953; year of death: 2009; age at diagnosis: 20665; ajcc pathologic m: M0; ajcc pathologic n: N3; ajcc pathologic stage: Stage IV; ajcc pathologic t: T4; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C16.0; last known disease status: not reported; morphology: 8490/3; primary diagnosis: Signet ring cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cardia, NOS; synchronous malignancy: No; tissue or organ of origin: Cardia, NOS; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1709; days to sample procurement: 0; initial weight: 220.0; portion submitter id: TCGA-VQ-A8PM-01A-21; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 2.0; percent necrosis: 10.0; percent neutrophil infiltration: 4.0; percent normal cells: 4.0; percent stromal cells: 16.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0;